Weiss Multi-Strategy Advisers’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-66,722	Closed	-$5.02M	–	811
2022 Q2	$5.02M	Buy	66,722 +54,798	+460%	+$2.44M	0.15%	213
2022 Q1	$320K	Sell	11,924 -1,009	-8%	-$33.9K	0.01%	602
2021 Q4	$617K	Sell	12,933 -81	-0.6%	-$3.62K	0.01%	531
2021 Q3	$865K	Buy	13,014 +6,674	+105%	+$475K	0.02%	504
2021 Q2	$495K	Buy	6,340 +226	+4%	+$16.7K	0.01%	551
2021 Q1	$578K	Buy	6,114 +518	+9%	+$61.6K	0.01%	536
2020 Q4	$682K	Buy	+5,596	New	+$613K	0.01%	529

Weiss Multi-Strategy Advisers's TPTX Position: Q3 2022 in Review

Weiss Multi-Strategy Advisers sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 66,722 shares — an estimated $5.02M sold.

Weiss Multi-Strategy Advisers first reported a position in TPTX in Q4 2020 and held it in 7 quarters. The position peaked at $5.02M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Weiss Multi-Strategy Advisers reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 66,722 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $5.02M.
Weiss Multi-Strategy Advisers first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Turning Point Therapeutics, Inc. Common Stock position peaked at $5.02M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.